Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells

Combination effects of docetaxel (DOC) and doxorubicin (DOX) were investigated in prostate cancer cells (PC3 and DU145). Combination indices (CIs) were determined using the unified theory in various concentrations and mixing ratios (synergy: CI < 0.9, additivity: 0.9 < CI < 1.1, and antagon...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsakalozou, Eleftheria, Eckman, Allison M., Bae, Younsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395329/
https://www.ncbi.nlm.nih.gov/pubmed/22811914
http://dx.doi.org/10.1155/2012/832059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395329/
https://www.ncbi.nlm.nih.gov/pubmed/22811914
http://dx.doi.org/10.1155/2012/832059

Ejemplares similares